The attorney general claims that the physicians who were testing the ProDisc were, in many cases, recommending its use to patients, and nearly half of those testing the product were being compensated with company stock for doing so.
Synthes has agreed to disclose any future payments or investments held by doctors involved in researching its products through its Web site and will pay $236,000 to reimburse the attorney general’s office for its investigation.
Read the New York Times’ report on the Synthes settlement.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.